ENDOPHTHALMITIS INCIDENCE AFTER VITRECTOMY: A Systematic Review and Meta-Analysis of Risk Factors and Prevention Strategy.

RetinaSep 1, 2026
Clinical ResearchOphthalmology

Robert McGrath, Liam Mulcahy, Abdulrahman Al Abri et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the incidence of endophthalmitis after vitrectomy across 69 studies involving 1,979,160 procedures. The overall incidence was found to be 0.14%. The analysis revealed that non-fluid intraocular tamponade significantly reduced endophthalmitis rates, while prophylactic subconjunctival antibiotics did not show a benefit.

Key findings

  • Endophthalmitis incidence after vitrectomy was 0.14%.
  • 25-gauge instruments had a significantly higher endophthalmitis risk compared to 23-gauge (OR 2.03).
  • Non-fluid intraocular tamponade was associated with significantly lower endophthalmitis rates (OR 0.15).
  • Prophylactic subconjunctival antibiotics did not reduce endophthalmitis risk compared to topical antibiotics (OR 0.77).

Why it matters

Understanding the incidence and risk factors for endophthalmitis after vitrectomy is crucial for improving surgical outcomes. This study highlights effective strategies for minimizing this serious complication, which can impact patient vision and quality of life.

Source

PubMed · PMID 41707079

Published in Retina. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.